Velonivex represents a groundbreaking development in the realm of oncology. This novel therapeutic agent operates on a unprecedented mechanism, targeting mutated proteins that are vital to cancer progression. Unlike traditional treatments, Velonivex aims to destroy cancer cells while limiting harm to normal cells. Clinical trials have shown promisi